A multicenter, double-blind, randomized, active controlled, parallel-group study to evaluate the efficacy, safety, tolerability and pharmacodynamic profiles of TL011 infusions compared with MabThera (rituximab) in subjects with severe, active rheumatoid arthritis treated with methotrexate (MTX)

Trial Profile

A multicenter, double-blind, randomized, active controlled, parallel-group study to evaluate the efficacy, safety, tolerability and pharmacodynamic profiles of TL011 infusions compared with MabThera (rituximab) in subjects with severe, active rheumatoid arthritis treated with methotrexate (MTX)

Suspended
Phase of Trial: Phase III

Latest Information Update: 04 May 2013

At a glance

  • Drugs Rituximab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms ALTO
  • Most Recent Events

    • 23 Jun 2012 Additional trial location (Netherlands) added as reported by European Clinical Trials Database.
    • 26 May 2012 Additional locations added as reported by European Clinical Trials Database record.
    • 24 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top